4,49 €
SOLDES
Jusqu'à -70% sur une sélection d'articles*
Satanwake
Par : ,Formats :
Disponible dans votre compte client Decitre ou Furet du Nord dès validation de votre commande. Le format ePub est :
- Compatible avec une lecture sur My Vivlio (smartphone, tablette, ordinateur)
- Compatible avec une lecture sur liseuses Vivlio
- Pour les liseuses autres que Vivlio, vous devez utiliser le logiciel Adobe Digital Edition. Non compatible avec la lecture sur les liseuses Kindle, Remarkable et Sony
, qui est-ce ?Notre partenaire de plateforme de lecture numérique où vous retrouverez l'ensemble de vos ebooks gratuitement
Pour en savoir plus sur nos ebooks, consultez notre aide en ligne ici
C'est si simple ! Lisez votre ebook avec l'app Vivlio sur votre tablette, mobile ou ordinateur :
- FormatePub
- ISBN8988003304
- EAN9798988003304
- Date de parution02/05/2023
- Protection num.pas de protection
- Infos supplémentairesepub
- ÉditeurStudio 1 Imprints
Résumé
A struggling pharmaceutical firm is in desperate need of a new product in order to survive. Led by a CEO desperate to achieve the fame and fortune he had always expected but had not yet gained, he and his firm are running out of time. On the precipice of bankruptcy, a technological breakthrough is close to fruition. They are in position to finally succeed, if they can only mobilize the resources to conduct a clinical trial that proves the product works.
Then a reclusive businessman fortuitously appears and strikes a deal with the CEO. The clinical trial shows their genetically engineered product involving a gene called STK17A works beyond even their wildest imagination. After special friends of his benefactor intervene to win necessary governmental approvals, the new product is hastily released to the public. And it becomes a success like no other.
Suddenly, everything he had ever wanted was his: money, celebrity, a beautiful partner, a leading international business, he had it all. But then a discovery is made. Had the clinical trial missed something, or was information maliciously left out? Now, he learns that the invention that had made his dreams come to fruition wasn't going to just change the world. It was going to end it.
Then a reclusive businessman fortuitously appears and strikes a deal with the CEO. The clinical trial shows their genetically engineered product involving a gene called STK17A works beyond even their wildest imagination. After special friends of his benefactor intervene to win necessary governmental approvals, the new product is hastily released to the public. And it becomes a success like no other.
Suddenly, everything he had ever wanted was his: money, celebrity, a beautiful partner, a leading international business, he had it all. But then a discovery is made. Had the clinical trial missed something, or was information maliciously left out? Now, he learns that the invention that had made his dreams come to fruition wasn't going to just change the world. It was going to end it.
